As of Apr 28
| -0.01 / -0.38%|
The 5 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 2.75, with a high estimate of 5.00 and a low estimate of 1.50. The median estimate represents a +4.96% increase from the last price of 2.62.
The current consensus among 6 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.